SEIZERT CAPITAL PARTNERS, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1134283
BIRMINGHAM, MI
Position in NBIX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$46,742,377
+$35,194,049 QoQ
Shares Held
277,337
+216.4% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
#64
of 772 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEIZERT CAPITAL PARTNERS, LLC holds $94,363,768 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (49.5% of the industry book) .
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,742,377 | 277,337 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $11,548,328 | 87,660 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $10,023,126 | 70,670 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $9,831,513 | 70,035 | Shares | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||